Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions
Abstract Treatment of choice for nodular basal-cell carcinomas (BCCs) is complete excision, implying that small lesions are of minor concern. Metastasis is very rare (< 1%). However, locally advanced basal-cell carcinomas (laBCCs), which are ineligible for surgery or radiation, are a therapeutic...
Main Authors: | Dennis Niebel, Judith Sirokay, Friederike Hoffmann, Anne Fröhlich, Thomas Bieber, Jennifer Landsberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-05-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-020-00382-y |
Similar Items
-
Vismodegib for the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
by: Concetta Laliscia, et al.
Published: (2019-12-01) -
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
by: Jain S, et al.
Published: (2017-03-01) -
Clinicopathological evaluation of radiation induced basal cell carcinoma
by: Meibodi Naser, et al.
Published: (2008-01-01) -
Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
by: Maxwell G. Su, et al.
Published: (2020-09-01) -
Giant Basal Cell Carcinoma: A Case Report
by: Popović Danijela, et al.
Published: (2018-06-01)